Emerging Markets Earnings Roundup: J&J, Abbott And Roche (Part 1)
This article was originally published in PharmAsia News
Executive Summary
Abbott moved to recover from recall and pricing issues for infant formula in China while Johnson & Johnson updated its device business and Roche reported strong growth in emerging markets.